Analyst Ratings for Regeneron Pharma (REGN)

REGN Rating Summary

REGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on REGN
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $699.16 (+14.2%) * Over Last 12-Mos
Rating Score: 6.1 / 10   Percentile Rank: 62%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/6/2022 Jefferies Akash Tewari New Coverage Underperform
(N/A)
536.00
(N/A)
630.70
(612.49)
-2.89% Details
5/23/2022 SVB Leerink Andrew Berens New Coverage Outperform
(N/A)
738.00
(N/A)
657.15
(612.49)
-6.8% Details
Like REGN Ratings? Also take a look at SNY, NTLA, CMPI, SAN

REGN Ratings News